Attributed risk to smoking for lung cancer, laryngeal cancer and esophageal cancer

Bibliographic Details
Main Author: Menezes, Ana MB
Publication Date: 2002
Other Authors: Horta, Bernardo L, Oliveira, André Luiz B, Kaufmann, Ricardo AC, Duquia, Rodrigo, Diniz, Alessandro, Motta, Luiz Henrique, Centeno, Marco S, Estanislau, Gustavo, Gomes, Laura
Format: Article
Language: por
Source: Revista de Saúde Pública
Download full: https://www.revistas.usp.br/rsp/article/view/25313
Summary: OBJECTIVE:Lung, laryngeal and esophageal cancers have smoking as one of their main risk factors. The objective of this study was to evaluate the population attributed risk (PAR) of smoking for these forms of cancer. METHODS: The study was based in three case-control studies conducted in medium size cities in Brazil. Incident cases of lung cancer, laryngeal cancer and esophageal cancer seen at a hospital setting and diagnosed through biopsy were analyzed; controls were hospitalized patients with another diagnoses. Smoking was the exposure factor measured at three levels: non-smokers, former smokers and smokers, which were defined using a questionnaire applied by trained interviewers. For effect measure, odds ratio was used and the populational attributed risk for smoking was then calculated for a 95% CI. RESULTS: A total of 122 lung cancer cases and 244 controls, 50 cases of laryngeal cancer and 48 cases of esophageal cancer, and 96 controls for both of them were studied. The prevalence of smoking exposure was 34%, which is the overall prevalence of smoking in this city's adult population. Odds ratios (OR) for the PAR analysis were the adjusted OR for confounding variables from each study. Lung cancer PAR was 63% (95% IC, 0.58-0.68) for former smokers and 71% (95%IC, 0.65-0.77) for smokers. Larynx cancer PAR was 74% (95% IC, 0.70-0.78) and 86% (95%IC, 0.81-0.85) for former smokers and smokers, respectively. Esophageal cancer PAR was 54% (95%IC, 0.46-0.62) for smokers. CONCLUSION: Smoking is an avoidable risk factor and smoking cessation could be responsible for significant reductions in the incidence of these three forms of cancer.
id USP-23_15971d935af544f99131a19d804a5652
oai_identifier_str oai:revistas.usp.br:article/25313
network_acronym_str USP-23
network_name_str Revista de Saúde Pública
repository_id_str
spelling Attributed risk to smoking for lung cancer, laryngeal cancer and esophageal cancer Risco de câncer de pulmão, laringe e esôfago atribuível ao fumo TabagismoNeoplasias pulmonaresNeoplasias laríngeasNeoplasias esofágicasRisco atribuívelEstudos de casos e controlesSmokingLung neoplasmsLaryngeal neoplasmsEsophageal neoplasmsAttributable riskCase-control studies OBJECTIVE:Lung, laryngeal and esophageal cancers have smoking as one of their main risk factors. The objective of this study was to evaluate the population attributed risk (PAR) of smoking for these forms of cancer. METHODS: The study was based in three case-control studies conducted in medium size cities in Brazil. Incident cases of lung cancer, laryngeal cancer and esophageal cancer seen at a hospital setting and diagnosed through biopsy were analyzed; controls were hospitalized patients with another diagnoses. Smoking was the exposure factor measured at three levels: non-smokers, former smokers and smokers, which were defined using a questionnaire applied by trained interviewers. For effect measure, odds ratio was used and the populational attributed risk for smoking was then calculated for a 95% CI. RESULTS: A total of 122 lung cancer cases and 244 controls, 50 cases of laryngeal cancer and 48 cases of esophageal cancer, and 96 controls for both of them were studied. The prevalence of smoking exposure was 34%, which is the overall prevalence of smoking in this city's adult population. Odds ratios (OR) for the PAR analysis were the adjusted OR for confounding variables from each study. Lung cancer PAR was 63% (95% IC, 0.58-0.68) for former smokers and 71% (95%IC, 0.65-0.77) for smokers. Larynx cancer PAR was 74% (95% IC, 0.70-0.78) and 86% (95%IC, 0.81-0.85) for former smokers and smokers, respectively. Esophageal cancer PAR was 54% (95%IC, 0.46-0.62) for smokers. CONCLUSION: Smoking is an avoidable risk factor and smoking cessation could be responsible for significant reductions in the incidence of these three forms of cancer. OBJETIVO: Os tipos de câncer de pulmão, laringe e esôfago têm como um de seus principais fatores de risco o fumo. O objetivo do estudo foi avaliar o risco populacional atribuível ao fumo nesses tipos de câncer. MÉTODOS: A pesquisa baseou-se em três estudos de caso-controle em cidade de médio porte do Brasil. Analisaram-se casos incidentes hospitalares de câncer de pulmão, de laringe e de esôfago diagnosticados por biópsias; os controles foram pacientes hospitalizados por outros motivos, sem ser câncer ou doenças altamente relacionadas ao fumo. O fator de exposição foi o tabagismo medido em três níveis: não-fumantes, ex-fumantes e fumantes atuais, definidos por meio de questionários aplicados por entrevistadores treinados. Para a medida de efeito, foi utilizado o odds ratio obtendo-se, dessa forma, o "risco populacional atribuível" ao fumo com IC de 95%. RESULTADOS: Foram estudados 122 casos e 244 controles de câncer de pulmão, 50 casos de câncer de laringe e 48 casos de câncer de esôfago, com um grupo de 96 controles comum a ambos. A prevalência da exposição ao fumo utilizada para a análise foi de 34%, que corresponde à prevalência de fumo na população adulta da cidade. Os odds ratios para o cálculo do risco populacional atribuível foram obtidos por análises ajustadas para os fatores de confusão de cada um dos estudos. Para ex-fumantes com câncer de pulmão, o risco populacional atribuível foi de 63% (IC95%, 0,58-0,68) e, para fumantes, de 71% (IC95%, 0,65-0,77). Para câncer de laringe, o RPA foi de 74% (IC95%, 0,70-0,78) para ex-fumantes e de 86% (IC95%, 0,81-0,85) para fumantes. O câncer de esôfago mostrou um risco de 54% (IC95%, 0,46-0,62) para fumantes. CONCLUSÃO: Conclui-se que o fumo é um importante fator de risco e que a cessação do mesmo contribuiria para reduções significativas na incidência de câncer nesses três sítios. Universidade de São Paulo. Faculdade de Saúde Pública2002-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/rsp/article/view/2531310.1590/S0034-89102002000200002Revista de Saúde Pública; Vol. 36 No. 2 (2002); 129-134 Revista de Saúde Pública; Vol. 36 Núm. 2 (2002); 129-134 Revista de Saúde Pública; v. 36 n. 2 (2002); 129-134 1518-87870034-8910reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USPporhttps://www.revistas.usp.br/rsp/article/view/25313/27058Copyright (c) 2017 Revista de Saúde Públicainfo:eu-repo/semantics/openAccessMenezes, Ana MBHorta, Bernardo LOliveira, André Luiz BKaufmann, Ricardo ACDuquia, RodrigoDiniz, AlessandroMotta, Luiz HenriqueCenteno, Marco SEstanislau, GustavoGomes, Laura2012-05-29T19:22:21Zoai:revistas.usp.br:article/25313Revistahttps://www.revistas.usp.br/rsp/indexONGhttps://www.revistas.usp.br/rsp/oairevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2012-05-29T19:22:21Revista de Saúde Pública - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Attributed risk to smoking for lung cancer, laryngeal cancer and esophageal cancer
Risco de câncer de pulmão, laringe e esôfago atribuível ao fumo
title Attributed risk to smoking for lung cancer, laryngeal cancer and esophageal cancer
spellingShingle Attributed risk to smoking for lung cancer, laryngeal cancer and esophageal cancer
Menezes, Ana MB
Tabagismo
Neoplasias pulmonares
Neoplasias laríngeas
Neoplasias esofágicas
Risco atribuível
Estudos de casos e controles
Smoking
Lung neoplasms
Laryngeal neoplasms
Esophageal neoplasms
Attributable risk
Case-control studies
title_short Attributed risk to smoking for lung cancer, laryngeal cancer and esophageal cancer
title_full Attributed risk to smoking for lung cancer, laryngeal cancer and esophageal cancer
title_fullStr Attributed risk to smoking for lung cancer, laryngeal cancer and esophageal cancer
title_full_unstemmed Attributed risk to smoking for lung cancer, laryngeal cancer and esophageal cancer
title_sort Attributed risk to smoking for lung cancer, laryngeal cancer and esophageal cancer
author Menezes, Ana MB
author_facet Menezes, Ana MB
Horta, Bernardo L
Oliveira, André Luiz B
Kaufmann, Ricardo AC
Duquia, Rodrigo
Diniz, Alessandro
Motta, Luiz Henrique
Centeno, Marco S
Estanislau, Gustavo
Gomes, Laura
author_role author
author2 Horta, Bernardo L
Oliveira, André Luiz B
Kaufmann, Ricardo AC
Duquia, Rodrigo
Diniz, Alessandro
Motta, Luiz Henrique
Centeno, Marco S
Estanislau, Gustavo
Gomes, Laura
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Menezes, Ana MB
Horta, Bernardo L
Oliveira, André Luiz B
Kaufmann, Ricardo AC
Duquia, Rodrigo
Diniz, Alessandro
Motta, Luiz Henrique
Centeno, Marco S
Estanislau, Gustavo
Gomes, Laura
dc.subject.por.fl_str_mv Tabagismo
Neoplasias pulmonares
Neoplasias laríngeas
Neoplasias esofágicas
Risco atribuível
Estudos de casos e controles
Smoking
Lung neoplasms
Laryngeal neoplasms
Esophageal neoplasms
Attributable risk
Case-control studies
topic Tabagismo
Neoplasias pulmonares
Neoplasias laríngeas
Neoplasias esofágicas
Risco atribuível
Estudos de casos e controles
Smoking
Lung neoplasms
Laryngeal neoplasms
Esophageal neoplasms
Attributable risk
Case-control studies
description OBJECTIVE:Lung, laryngeal and esophageal cancers have smoking as one of their main risk factors. The objective of this study was to evaluate the population attributed risk (PAR) of smoking for these forms of cancer. METHODS: The study was based in three case-control studies conducted in medium size cities in Brazil. Incident cases of lung cancer, laryngeal cancer and esophageal cancer seen at a hospital setting and diagnosed through biopsy were analyzed; controls were hospitalized patients with another diagnoses. Smoking was the exposure factor measured at three levels: non-smokers, former smokers and smokers, which were defined using a questionnaire applied by trained interviewers. For effect measure, odds ratio was used and the populational attributed risk for smoking was then calculated for a 95% CI. RESULTS: A total of 122 lung cancer cases and 244 controls, 50 cases of laryngeal cancer and 48 cases of esophageal cancer, and 96 controls for both of them were studied. The prevalence of smoking exposure was 34%, which is the overall prevalence of smoking in this city's adult population. Odds ratios (OR) for the PAR analysis were the adjusted OR for confounding variables from each study. Lung cancer PAR was 63% (95% IC, 0.58-0.68) for former smokers and 71% (95%IC, 0.65-0.77) for smokers. Larynx cancer PAR was 74% (95% IC, 0.70-0.78) and 86% (95%IC, 0.81-0.85) for former smokers and smokers, respectively. Esophageal cancer PAR was 54% (95%IC, 0.46-0.62) for smokers. CONCLUSION: Smoking is an avoidable risk factor and smoking cessation could be responsible for significant reductions in the incidence of these three forms of cancer.
publishDate 2002
dc.date.none.fl_str_mv 2002-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/rsp/article/view/25313
10.1590/S0034-89102002000200002
url https://www.revistas.usp.br/rsp/article/view/25313
identifier_str_mv 10.1590/S0034-89102002000200002
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.revistas.usp.br/rsp/article/view/25313/27058
dc.rights.driver.fl_str_mv Copyright (c) 2017 Revista de Saúde Pública
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2017 Revista de Saúde Pública
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Saúde Pública
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Saúde Pública
dc.source.none.fl_str_mv Revista de Saúde Pública; Vol. 36 No. 2 (2002); 129-134
Revista de Saúde Pública; Vol. 36 Núm. 2 (2002); 129-134
Revista de Saúde Pública; v. 36 n. 2 (2002); 129-134
1518-8787
0034-8910
reponame:Revista de Saúde Pública
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Revista de Saúde Pública
collection Revista de Saúde Pública
repository.name.fl_str_mv Revista de Saúde Pública - Universidade de São Paulo (USP)
repository.mail.fl_str_mv revsp@org.usp.br||revsp1@usp.br
_version_ 1787713220575756288